Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2347${count})

  • Target Validation, 2014
    Targeting the Stress Sensor PERK for the Treatment of Parkinson´s Disease

    Objective/Rationale:             
    Parkinson's disease (PD) is characterized by impairment of motor control as a result from extensive neuron death. The primary mechanism responsible for the progressive...

  • Improved Neuromodulation Approaches, 2014
    Optogenetic Restoration of Basal Ganglia Function to Treat Parkinson’s Disease

    Study Rationale:                   
    Optogenetics has gained wide interest as a tool to understand the function of circuits influencing brain diseases. This approach uses proteins that respond to...

  • Improved Neuromodulation Approaches, 2014
    Machine Learning for Programming Deep Brain Stimulation Arrays

    Study Rationale:                   
    Deep brain stimulation (DBS) implants for treating Parkinson’s disease currently consist of four round electrodes stacked along a thin cylindrical carrier lead. When...

  • Improved Neuromodulation Approaches, 2014
    Multicenter Clinical Trial of Deep Brain Stimulation in Early Stage Parkinson’s Disease

    Study Rationale:
    Deep brain stimulation (DBS) is an effective treatment for many patients with advanced stage Parkinson’s disease (PD) when symptoms are not adequately controlled with medication...

  • Improved Neuromodulation Approaches, 2014
    Chronic Directional Deep Brain Stimulation in Parkinson’s Disease

    Study Rationale:       
    The side effects of deep brain stimulation (DBS) in Parkinson’s disease are related to overstimulation of the brain target structure and neighboring regions. This clinical study...

  • Research Grant, 2014
    Phase IIb Study of Intranasal Glutathione in Parkinson's Disease

    Study Rationale:
    The loss of glutathione in the brain of individuals with PD occurs years before the onset of motor symptoms. Glutathione has been proposed as neuroprotective therapy in PD for decades...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.